Recent clinical trials in PKD suggest that a lower blood pressure and the use of renin-angiotensin inhibitors reduces the growth rate of renal cysts in PKD (albeit to a small extent of ~14% over an 8 year period) but do not alter the long-term decline in renal function [15]. The gene discussed is REN; the disease is cystic kidney disease.